Description of 3 Cases in Vietnam of Aspirin Desensitization in Patients With Coronary Artery Disease and Coexisting Aspirin Hypersensitivity
Aspirin (ASA) hypersensitivity comprises types I to III (Cox-1 mediated) and types IV and V (IgE antibody mediated). Rapid, low-dose (81-325 mg/day) ASA desensitization regimens are known to be useful in establishing ASA tolerance in patients with coronary artery disease and coexisting ASA/nonsteroi...
Main Authors: | Dinh Van Nguyen, MD, Hieu Chu Chi, MD, Doan Van Nguyen, MD, PhD, Timothy J. Craig, DO, Sheryl van Nunen, MB, BS, MM, FRACP |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2012-01-01
|
Series: | World Allergy Organization Journal |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1939455119303977 |
Similar Items
-
The role of aspirin desensitization in patients with aspirin-exacerbated respiratory disease (AERD)
by: Jonas Willian Spies, et al. -
The impact of endoscopic sinus surgery and aspirin desensitization on psychological burden in aspirin-exacerbated respiratory disease
by: Tran Locke, et al.
Published: (2020-12-01) -
Long-term efficacy of aspirin desensitization in aspirin-exacerbated respiratory disease. Review of two clinical cases
by: Julio César Cambray-Gutiérrez, et al.
Published: (2016-05-01) -
Systematic review of outcomes for endoscopic sinus surgery and subsequent aspirin desensitization in aspirin-exacerbated respiratory disease
by: Lindsey Ryan, et al.
Published: (2020-12-01) -
The Effect of Aspirin on Moderate to Severe Asthmatic Patients with Aspirin Hypersensitivity, Chronic Rhinosinusitis, and Nasal Polyposis
by: Saba Arshi, et al.
Published: (2021-06-01)